Response of dehydroepiandrosterone to corticotropin-releasing hormone stimulation in alcohol-dependent subjects

Biological Psychiatry

Volumn 40, Issue 12, 1996, Pages 1305-1307

  Adinoff, Bryon ^a,e   Cantey Kiser, Jean M ^b   Martin, Peter R ^c   Linnoila, Markku ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

alcoholism; corticotropin; hypothalamic hypophyseal system; steroids

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PRASTERONE;

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; HUMAN; PRIORITY JOURNAL;

ADULT; ALCOHOLISM; CORTICOTROPIN-RELEASING HORMONE; DEHYDROEPIANDROSTERONE; HUMANS; TEMPERANCE;

EID: 0030589685     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00381-2     Document Type: Article

References (15)

1. Adinoff B, Martin PR, Bone GHA, et al (1990): Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry 47:325-330.
2. Barrett-Connor E, Khaw K-T, Yen SSC (1986): A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519-1524.
3. Buster JE, Abraham GE (1972): Radioimmunoassay of plasma dehydroepiandrosterone. Anal Lett 5:203-215.
4. Cleary MP (1990): Effect of dehydroepiandrosterone treatment on liver metabolism in rats. Int J Biochem 22:205-210.
5. Coleman DL, Leiter EH, Schwizer RW (1984): Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. J Nutr 114:1242-1251.
6. Flood FJ, Smith GE, Roberts E (1988): Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447:269-278.
7. Lopez S, Wingo C, Hebert JA (1976): Total serum cholesterol and urinary dehydroepiandrosterone in humans. Atherosclerosis 24:471-481.
8. Mayer EJ, Newman B, Quesenberry CP, Friedman GD, Selby JV (1993): Alcohol consumption and insulin concentration. Circulation 88:2190-2197.
9. Merrill CR, Harrington MG, Sunderland T (1989): Plasma dehydroepiandrosterone levels in HIV infection. JAMA 261:1149.
10. Nestler JE, Barlascini CO, Clore JN, Blackard WG (1988): Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66:57-61.
11. Nestler JE, McClanahan MA, Clore JN, Blackard WG (1992): Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab 74:362-367.
12. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984): Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555.
13. Parker LN, Levin ER, Lifrak ET (1985): Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 60:947-952.
14. Pavlov EP, Harman SM, Chrousos GP, Loriaux DL, Blackman MR (1986): Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J Clin Endocrinol Metab 62:767-772.
15. Tourney G, Hatfield L (1972): Plasma androgens in male schizophrenics. Arch Gen Psychiatry 27:753-755.